About Kayley Szanto

This author has not yet filled in any details.
So far Kayley Szanto has created 46 blog entries.

Marijuana stocks drop as Trudeau’s pot czar says Canada won’t rush into legalization

As investors flock to Canada’s burgeoning marijuana sector, Prime Minister Justin Trudeau’s government is signaling recreational pot sales aren’t imminent. Lawmaker Bill Blair -- the former Toronto police chief leading Trudeau’s legalization effort -- confirmed a bill is due in parliament this spring, but it won’t be the last hurdle as ample regulatory work remains. The federal government will take its time and work with provinces, territories and cities to build a framework and develop specific regulations, he said. The government is also looking for ways to control production, distribution and consumption of legalized marijuana, while testing it for quality and keeping it out of the hands of minors, Mr. Blair said. “We will take [...]

By | 2017-03-07T15:02:27+00:00 March 7th, 2017|Blog, News|Comments Off on Marijuana stocks drop as Trudeau’s pot czar says Canada won’t rush into legalization

Israel moves to decriminalize marijuana

JERUSALEM -- Holy smokes! The Israeli government has taken a step toward decriminalizing marijuana use. Israeli media say Prime Minister Benjamin Netanyahu's Cabinet has approved a measure that would reduce penalties for possession of marijuana. If caught, smokers would pay a fine, instead of facing criminal charges. Netanyahu said ahead of Sunday's meeting that a "new enforcement policy" should be drawn up "cautiously and in a controlled manner." The decision does not mean that Jerusalem will now have Amsterdam-style coffee shops. The Haaretz daily said a committee would study ways to regulate the use of pot. Opposition lawmaker Tamar Zandberg told Haaretz: "This is an important step, but not the end of the road. It [...]

By | 2017-03-06T14:21:58+00:00 March 6th, 2017|Blog, News|Comments Off on Israel moves to decriminalize marijuana

Why doctors don’t want to be the gatekeepers of medical marijuana

There are concerns about the absence of peer-reviewed research, the possible side effects, and appropriate dosages. VANCOUVER – Not all medicinal marijuana is created equal. That’s what some experts are saying as they warn about the health risks and curtailed effectiveness associated with smoking medicine. As medical pot becomes increasingly mainstream and Canada moves toward legalizing the substance, health experts are emphasizing the need for doctors and patients to consider the sometimes serious side effects linked to the various ways of consuming the drug. Paul Farnan, an addictions specialist at the University of British Columbia, likened a recommendation to smoke medicinal marijuana to a doctor handing out a prescription to light up an opium pipe. [...]

By | 2017-03-06T09:51:46+00:00 March 6th, 2017|Blog, News|Comments Off on Why doctors don’t want to be the gatekeepers of medical marijuana

Q&A Former premier Darrell Dexter now a lobbyist for marijuana industry

Darrell Dexter's newest interest is marijuana. The former NDP premier of Nova Scotia is a vice-chair at Global Public Affairs, the country's largest privately held government relations firm. Dexter will be leading the firm's cannabis industry clients as marijuana legislation and regulations are rolled out. He spoke by phone from Calgary with the CBC's Elizabeth Chiu. The interview has been edited for length and clarity. Q: Why are you interested in lobbying for the marijuana industry? A: You might know that a recent Deloitte report on this industry says that it will, in all likelihood, reach something in the order of a $22-billion industry, in fact eclipsing the combined sales of beer, wine and spirits. This [...]

By | 2017-03-02T10:33:09+00:00 March 2nd, 2017|Blog, News|Comments Off on Q&A Former premier Darrell Dexter now a lobbyist for marijuana industry

The ‘Tesla of cannabis’ is opening a massive, custom-built marijuana greenhouse

A marijuana cultivator that's been called the "Tesla of cannabis" is bringing the industry out of the darkness and into the light — literally. Tantalus Labs, which could start selling product as early as 2018, has wrapped construction on a state-of-the-art cultivation site designed to give marijuana plants the benefits of indoor and outdoor growing. The greenhouse lets sunlight pour in, enabling the plants to grow fuller buds faster. Shafin Diamond, a prominent Canadian angel investor, gave Tantalus Labs the moniker "Tesla of cannabis" because of the company's dedication to pioneering new, sustainable technologies. Like the company behind electric cars and aesthetically appealing solar panels, Tantalus Labs optimizes for environmental stewardship. Courtesy of Tantalus [...]

By | 2017-03-01T16:35:41+00:00 March 1st, 2017|Blog, News|Comments Off on The ‘Tesla of cannabis’ is opening a massive, custom-built marijuana greenhouse

Company in tainted cannabis scare shuffles top staff

A federally licensed medical marijuana company caught in the fallout from a recent tainted cannabis scare has shuffled its senior management ranks, naming a new chief executive officer. Organigram Inc., which was discovered selling products containing a banned pesticide that produces hydrogen cyanide when heated and can cause serious health problems in those who consume it, announced Wednesday that Greg Engel has been appointed CEO, taking over from Denis Arsenault. Mr. Arsenault, who ran the company for the past three years, is moving to the board of directors as executive chairman, Moncton-based Organigram said in a press release issued before markets opened. The move is the second high-profile shakeup at a federally licensed medical [...]

By | 2017-03-01T15:10:22+00:00 March 1st, 2017|Blog, News|Comments Off on Company in tainted cannabis scare shuffles top staff

Aphria Invests Aggressively into the Cannabis Industry

Most investors are familiar with Aphria (TSXV: APH) (OTC: APHQF) as a leading licensed producer in Canada, but many may not realize that it is rapidly building a substantial portfolio of investments in the North American cannabis industry, including nine different companies or funds in both the private and public markets. It has already experienced one profitable exit and some unrealized gains, one of which is quite significant, while one has not yet panned out. Here is a summary of its stakes in alphabetical order. Canabo Medical The company made a strategic investment into Canabo Medical (TSXV: CMM) (OTC: CAMDF) in late December, spending $8.4m to buy 6mm shares at $1.40. The 16.6% stake gives the company access to [...]

By | 2017-02-27T14:53:27+00:00 February 27th, 2017|Blog, News|Comments Off on Aphria Invests Aggressively into the Cannabis Industry

Company caught selling tainted marijuana can’t trace source of contamination

A federally regulated medical marijuana company caught selling products tainted with a banned pesticide that can cause debilitating health problems has been unable to determine how the chemical got into its supply, raising new questions about the oversight of the industry. Organigram Inc. said on Monday that it has wrapped up an internal investigation into a product recall announced in December, but has turned up “inconclusive findings” with “no hard evidence leading to the source of the contamination.” The company also said it would offer full refunds to customers who purchased the tainted product, after initially refusing over the past two months to give patients their money back. The refunds will cost $2.26-million, Organigram said, [...]

By | 2017-02-27T14:43:24+00:00 February 27th, 2017|Blog, News|Comments Off on Company caught selling tainted marijuana can’t trace source of contamination

Canadian Marijuana Stocks Tumble As Trump White House Talks Crackdown

TORONTO — Shares of Canadian and U.S. marijuana producers fell Friday after the Trump administration suggested a crackdown on recreational marijuana may be in the works. Most of Canada’s publicly traded pot growers ended Friday lower after White House Press Secretary Sean Spicer predicted the Justice Department will be looking more closely at the issue. “I do believe that you’ll see greater enforcement of it,” Spicer said at a White House briefing. Spicer said “there is a big difference” between medical marijuana, which Congress has in effect condoned, and “recreational use, which is something the Department of Justice I think will be further looking into.” Ontario-based Canopy Growth Corp. (stock ticker symbol WEED), which bills [...]

By | 2017-02-27T14:37:48+00:00 February 27th, 2017|Blog, News|Comments Off on Canadian Marijuana Stocks Tumble As Trump White House Talks Crackdown

Canadian medical marijuana company to make its own lab-test results public

A Canadian medical marijuana company has taken matters into its own hands amid a tainted cannabis scare that has left Health Canada struggling to reassure patients the products sold by federally licensed producers can be trusted. CanniMed Therapeutics Inc., based in Saskatoon, has taken the unusual step of commissioning independent lab tests on some of its products and making the data public to show consumers that its medicine contains no banned pesticides. The move is an effort by the company to distance itself from industry recalls over the past few months since three federally licensed producers were caught selling medical marijuana that contained the banned pesticide myclobutanil. The chemical emits hydrogen cyanide when burned and [...]

By | 2017-02-24T12:16:40+00:00 February 24th, 2017|Blog, News|Comments Off on Canadian medical marijuana company to make its own lab-test results public